학술논문
Reduced versus maximum tolerated methotrexate dose concomitant with adalimumab in patients with rheumatoid arthritis (MIRACLE): a randomised, open-label, non-inferiority trial
Document Type
Article
Author
Izumi, Keisuke; Kondo, Yasushi; Yoshimoto, Keiko; Gono, Takahisa; Park, Sung-Hwan; Baek, Han Joo; Lee, Yun Jong; Choi, In Ah; Kim, Jinhyun; Hsu, Ping-Ning; Huan, Chun-Ming; Weng, Meng-Yu; Sung, Wan-Yu; Cheng, Tien-Tsai; Tamai, Hiroya; Ikeda, Kei; Miyamoto, Toshiaki; Taguchi, Hiroaki; Kuo, Chang-Fu; Shin, Kichul; Hirata, Shintaro; Okano, Yutaka; Sato, Shinji; Yasuoka, Hidekata; Kuwana, Masataka; Ishii, Tomonori; Kameda, Hideto; Kojima, Toshihisa; Taninaga, Takehiro; Mori, Masahiko; Miyagishi, Hideaki; Sato, Yasunori; Tsai, Wen-Chan; Takeuchi, Tsutomu; Kaneko, Yuko
Source
In The Lancet Rheumatology April 2023 5(4):e215-e224
Subject
Language
ISSN
2665-9913